Skip to main content
. 2017 Feb 27;9(2):61–67. doi: 10.4240/wjgs.v9.i2.61

Table 4.

Published series on fibrolamellar hepatocellular carcinoma

Ref. n Age Male:female Cirrhosis/ hepatitis AFP elevated Median size (cm) > 1 tumor Positive node Vascular invasion Initial operation Repeat operation Median f/u 5 yr survival Prognostic factor
Hemming et al[18], 1997 10 31 50:50 NR 10% 8 20% 20% NR Phx 100% 50% 101 70% NR
El-Gazzaz et al[19], 2000 20 27 65:35 0% hep B 0% 14 20% 30% 55% Phx 55% OLT 45% NR 25 50% NONE
Kakar et al[20], 2005 20 27 53:27 0% 3/13 (23%) < 10 31% ≥ 10 69% 10% 35% NR Phx 100% NR NR 62% Metastasis at presentation
Stipa et al[21], 2006 28 28 43:57 0% 7% 9 11% 50% 36% Phx 100% 61% 34 76% Positive LN
Present study 22 29 50:50 9%/hepc 9% 12 13% 18% 23% Phx 100% 18% 42 65% Vascular invasiom

Hep: Hepatitis; AFP: Alpha-fetoprotein elevated (> 200 ng/mL); Phx: Partial hepatectomy; NR: Not reported; f/u: Follow up.